Comparison of the Effectiveness of Walking Back Exercises and Rebound Therapy in Cerebral Palsy Rehabilitation

NCT04694118 | Unknown

• 1 other identifier: 10840098-604.01.01-E.66352
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 2

Brief Summary

Purpose of the study: To investigate the effect of walking back exercises and rebound therapy on muscle strength, functionality, balance and aerobic capacity in children with CP Implication for rehabilitation:Determining the effects of rehabilitative interventions (back and forth walking exercises and rebound therapy) to be applied in children with CP with objective measurement methods (muscle US, tetrax balance system) and evaluating the effects of the results on functionality and respiratory parameters

Conditions

Cerebral Palsy, Spastic

Keywords

Cerebral palsy,; neurodevelopmental therapy

Outcome Measures

Primary Outcomes (1)

• changes in muscle volume

  ultrasonic imaging

  one measurement at the beginning of the study, second measurement 8 weeks later, 3rd measurement at 12th week following

Study Arms (2)

15 hemiparetic cerebral palsy,walking back group

EXPERIMENTAL

GMFM I or II degreed 6-15 age range hemiparetic cerebral palsy

Other: rebound therapy

15 hemiparetic cerebral palsy,rebound therapy group

EXPERIMENTAL

GMFM I or II degreed 6-15 age range hemiparetic cerebral palsy

Other: rebound therapy

Interventions

rebound therapy OTHER

3 days a week in 12 weeks

Also known as: walking back exercise

15 hemiparetic cerebral palsy,rebound therapy group; 15 hemiparetic cerebral palsy,walking back group

Eligibility Criteria

• Age: 6 Years - 15 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Being diagnosed with hemiparetic SP To be in the age range of 6-15 years, where effective communication can be provided in evaluation and treatment processes and when walking begins to mature Having adequate communication skills Being on level I or level II according to KMFSS No impairment in visual functions in terms of not affecting postural control responses, Children with family consent

You may not qualify if:

• Orthopedic surgery and / or botulinum toxin-A application for the lower extremity in the last 6 months Being at level III, level IV or level V according to KMFSS Severe convulsion situations that cannot be controlled with drugs Presence of a medical condition that prevents participation in the study Congenital malformation conditions accompanying CP

Sponsors & Collaborators

• Istanbul Medipol University Hospital: lead

Study Sites (2)

Umran medical center

Istanbul, Uskudar, Turkey (Türkiye)

RECRUITING

Ulku Atasoy

Istanbul, Ümraniye, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, Chronic; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases

Study Officials

• ulku atasoy, msc.pt

  PhD student

  PRINCIPAL INVESTIGATOR

Central Study Contacts

devrim tarakcı, assoc.prof.

CONTACT

4448544; dtarakci@medipol.edu.tr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Msc.physiotherapist

Model Details: randomise controlled clinical trial

Study Record Dates

• First Submitted: January 1, 2021
• First Posted: January 5, 2021
• Study Start: January 4, 2021
• Primary Completion: December 15, 2021
• Study Completion: December 15, 2021
• Last Updated: January 6, 2021

Record last verified: 2021-01

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: starting 6 months after publication).
• Access Criteria: Users and editors with journal memberships published for pubmed users

Locations

TU (2)